Compare IMUX & RAIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMUX | RAIL |
|---|---|---|
| Founded | 2016 | 1901 |
| Country | United States | United States |
| Employees | 66 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Railroads |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 209.2M | 235.1M |
| IPO Year | 2013 | 2005 |
| Metric | IMUX | RAIL |
|---|---|---|
| Price | $12.97 | $7.08 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | ★ 196.4K | 171.0K |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.00 | ★ 134.94 |
| EPS | N/A | ★ 0.32 |
| Revenue | N/A | ★ $500,991,000.00 |
| Revenue This Year | N/A | $6.54 |
| Revenue Next Year | N/A | $30.90 |
| P/E Ratio | ★ N/A | $21.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.51 | $6.57 |
| 52 Week High | $17.43 | $14.90 |
| Indicator | IMUX | RAIL |
|---|---|---|
| Relative Strength Index (RSI) | 28.95 | 39.88 |
| Support Level | $11.21 | N/A |
| Resistance Level | $15.82 | $8.70 |
| Average True Range (ATR) | 1.17 | 0.24 |
| MACD | -0.43 | -0.02 |
| Stochastic Oscillator | 7.58 | 45.46 |
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
FreightCar America Inc is a diversified manufacturer and supplier of railcars and railcar components. It designs and manufactures a variety of railcar types for transportation of bulk commodities and containerized freight products in North America. The company also provides railcar rebody and repair services, railcar conversion services, and supplies railcar parts. The company has two segments: Manufacturing and Aftermarket. The majority of the company's revenue is derived from the Manufacturing segment, which includes new railcar manufacturing, used railcar sales, and various conversions and rebodies. Geographically, it generates the maximum revenue from the United States.